Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Saccharomyces Boulardii on Fecal Resistome in H. Pylori Treatment
NCT04786938Phase 4Completed
- Sponsor
- Universidad San Francisco de Quito
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Microbiome Therapeutics
01
Overview
A Phase 4 trial of saccharomyces boulardii in Helicobacter pylori infection, sponsored by Universidad San Francisco de Quito. Started Apr 2016; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04786938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786938.